Clinical trial · Interventional
Exercise Following Autologous Peripheral Blood Stem Cell Transplantation
NCT00883961CI-TRIAL-00002921unknownPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study evaluates the effects of a supervised exercise program on the physical performance, the mood and the complications of therapy in patients undergoing a high-dose chemotherapy followed by an autologous peripheral blood stem cell transplantation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hematological Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Supervised exercise | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Supervised exercise
- interventionNames
- Other: Supervised exercise
- type
- NO_INTERVENTION
- label
- Control group
- description
- The patients will not carry out a structured exercise program.
Primary outcomes (1)
- measure
- VO2max
- timeFrame
- At recruitment and after 3 weeks
Secondary outcomes (4)
- measure
- Mood
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18-70 * Hematological disease * Treatment with high-dose chemotherapy followed by autologous stem cell transplantation * Understanding of written German Exclusion Criteria: * Cardiorespiratory, metabolical, osteoarticular or immunological diseases which can be aggravated by exercise * Pathological stress-ECG at admission
References
Publications (0)
Data not yet available
No reference posted for this study.